Our results have revealed both the activation of AMPK and S6K in the VMH and LH in response to changes in glucose concentration or nutritional state, and that GLP-1/exendin-4 acts by counteracting the activation/inactivation of these kinases and contributing to the balance of proper AMPK and S6K activation
Due to this role, it has gained popularity among athletes, active individuals, and those seeking to support their body composition goals
For laboratory use only
The GLP-1R arm drives the central appetite suppression, delayed gastric emptying, and glucose-dependent insulin secretion familiar from semaglutide and tirzepatide 24
Changes in body composition, energy levels, and muscle tone typically require 8-12 weeks of consistent use, though individual response varies based on dosing, lifestyle, and baseline growth hormone levels